🇺🇸 FDA
Patent

US 10815225

Antiproliferation compounds and uses thereof

granted A61PA61P35/00

Quick answer

US patent 10815225 (Antiproliferation compounds and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
50
CPC classes
A61P, A61P35/00